Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page, while the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-17T14:19:25.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T14:15:01.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, replacing the previous study record content with a standard site header, navigation, and footer. This indicates the record is not accessible at this time.
    Difference
    17%
    Check dated 2026-09-19T20:28:39.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page revision tag updated from v3.6.5 to v3.6.6. This reflects a small update to the page metadata.
    Difference
    0.1%
    Check dated 2026-08-29T19:51:40.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4 tag to reflect an updated platform version. This change is a metadata update and does not alter the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-08T16:57:49.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new release of the page content. This update documents a version change rather than affecting user-facing information.
    Difference
    0.1%
    Check dated 2026-07-25T09:24:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.